Category Archives: Global News Feed

DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company, pioneer in the exploration and exploitation of bacterial biodiversity to address the urgent, global challenge of antibiotic resistance, reminds its shareholders that they are convened to an Extraordinary General Meeting on October 17, 2022 at 2 p.m. CEST, in the premises of Fieldfisher, 48 rue Cambon, 75001 Paris.

Read the original post:
DEINOVE - Extraordinary General Meeting of October 17, 2022: Appointment of an ad hoc representative

New Network Provides Regulators, Industry With Tool to Further Protect Drug Supply Chain New Network Provides Regulators, Industry With Tool to Further Protect Drug Supply Chain

View original post here:
NABP Enters Final Development Phase of DSCSA Interoperability Network

PRESS RELEASE

See more here:
AB Science receives first agencies authorizations to initiate confirmatory Phase 3 clinical study with masitinib in the treatment of Alzheimer’s...

Fast-Track Grant will support ongoing preclinical development of a Vasculogenic Mimicry-blocking Antibody Fusion therapeutic for Triple Negative Breast Cancer Fast-Track Grant will support ongoing preclinical development of a Vasculogenic Mimicry-blocking Antibody Fusion therapeutic for Triple Negative Breast Cancer

See the article here:
Synergys Receives Third NIH SBIR Grant from National Cancer Institute

LONDON and PHOENIX, Oct. 10, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB:ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced today that its 2022 annual meeting of stockholders (the “Annual Meeting”) on October 10, 2022 at 9:00 a.m. Eastern Time was convened and adjourned, without any business being conducted, due to lack of the required quorum.

Link:
AccuStem Announces Adjournment of Annual Meeting of Stockholders

REGULATED INFORMATION

Original post:
Bone Therapeutics SA: Transparency notification received from S.F.P.I/F.P.I.M